Related by context. Frequent words. (Click for all words.) 82 pivotal Phase 74 Phase 1b 73 pivotal Phase III 73 Phase III clinical 72 Phase 2b clinical 71 Phase IIb 71 Phase Ib 70 Phase 2a clinical 69 Phase 2b 68 Phase 2a 68 Phase IIb clinical 68 Phase III 66 Phase IIa clinical 66 Phase 66 Phase IIb trial 66 randomized placebo controlled 66 dose escalation study 65 dose escalation 64 Phase III clinical trials 64 multicenter 64 randomized double 64 clinical trial 63 Phase IIa 63 Phase II 63 placebo controlled 63 randomized controlled 62 hormone refractory prostate cancer 61 Phase III trials 61 evaluable patients 61 double blind placebo 61 prospective randomized 61 randomized clinical 61 initiate Phase 60 blind randomized placebo 60 sunitinib 60 T DM1 59 FOLOTYN 59 carfilzomib 59 nimotuzumab 59 perifosine 59 NSCLC 58 randomized 58 RG# [001] 58 tivozanib 58 blind randomized 57 monotherapy 57 tolerability 57 RDEA# 57 picoplatin 57 clinical trials 57 metastatic colorectal cancer 57 XL# [003] 57 docetaxel 57 Vectibix 57 mipomersen 57 sorafenib 56 multicenter study 56 VELCADE 56 INCB# [002] 56 BiovaxID 56 ERBITUX 56 investigational drug 56 antitumor activity 56 REOLYSIN 55 PRX # 55 satraplatin 55 metastatic melanoma 55 advanced NSCLC 55 DSMB 55 Tovaxin 54 pharmacokinetic 54 blind placebo controlled 54 relapsing remitting multiple sclerosis 54 elesclomol 54 Dacogen 54 tolerability profile 54 oral formulation 54 CYT# 54 temozolomide 54 Genasense 54 carboplatin 54 hematologic malignancies 54 safety tolerability 53 gemcitabine 53 telaprevir 53 CTCL 53 randomized clinical trials 53 Prochymal 53 evaluable 53 dosing regimens 53 pharmacodynamic 53 Actemra 53 humanized monoclonal antibody 53 TMC# [001] 53 investigational 53 ARRY 52 randomized controlled trial 52 ANA# 52 rituximab 52 cell lung cancer 52 PROVENGE